A new review article online from Jonathan Cooper (mentor: Filippo G. Giancotti) at Cancer Cell: "Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity and Therapeutic Resistance."
Our faculty were invited to give talks and presentations at the following:
- Raghu Kalluri, M.D., Ph.D., presented at the AACR-JCA Joint Conference. He also presented at the Cancer Research Institute Ghent in Belgium, and at the 2nd Annual Symposium on Pancreatic Cancer.
- Ronald DePinho, M.D., was invited to speak at the Lake Nona Institute Forum. He also presented at the 2nd Annual Symposium on Pancreatic Cancer.
- Katharina Schlacher, Ph.D., presented on Mammalian DNA Repair at the Gordon Research Conference. She also presented at the Fusion Conference and the 3rd Annual Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference.
Cancer Biology welcomes two assistant professors joining the department
The Cancer Biology department welcomes Yejing Ge, Ph.D., and Fuguo Jiang, Ph.D., joining the department as tenure-track assistant professors. Ge trained at the Rockefeller University with Elaine Fuchs, Ph.D., working on skin epithelial stem cells and squamous cell carcinomas. Jiang trained at University of California, Berkeley with Jennifer Doudna, Ph.D., working on molecular and functional mechanisms of CRISPR.
Menashe Bar-Eli awarded new R21 NIH grant with a score of one percentile
Ronald A. DePinho awarded R01 funding by the NIH to study colorectal cancer
Ronald A. DePinho, M.D., was awarded R01 funding by the NIH to study colorectal cancer ("Genetics and Biology of Metastatic Colorectal Cancer”). The goal of this project is to dissect the mechanistic actions of oncogenic Kras and its circuitry in controlling CRC immune biology with the goal of illuminating effective therapeutic strategies for testing in CRC patients.
Ronald A. DePinho awarded R01 funding by the NIH to study pancreatic cancer
Ronald A. DePinho was awarded R01 funding by the NIH to study collateral lethality targets in pancreatic cancer ("Exploring Collateral Lethality for Development of Cancer Therapeutics"). This project aims to validate mitochondrial malic enzyme 3 (ME3) as a therapeutic target using in vitro analyses and preclinical animal models and to identify potential therapeutic compounds targeting ME3.
Rumi Lee awarded T32 Training Grant
Rumi Lee, Ph.D. candidate, in DePinho’s lab, was awarded a T32 Training Grant in Cancer Biology to study the synthetic essentiality of TDO2 in APC-mutated colorectal cancer.
Fatma Betul Aksoy Yasar receives Smith Education Fund
Fatma Betul Aksoy Yasar, Ph.D. candidate, in the Jian Hu, Ph.D., lab, was awarded the 2019 Smith Education Fund.
Seula Shin receives Russell and Dianna Hawkins Family Foundation Discovery Fellowship
Seula Shin, Ph.D. candidate, in Hu’s lab, was awarded the 2018-2019 Russell and Dianna Hawkins Family Foundation Discovery Fellowship.
Jian Hu receives NCI Young Faculty MERIT Award
Jian Hu, Ph.D., received the NCI Young Faculty Method to Extend Research in Time (MERIT)(R37) Award that provides longer term grant support to Early Stage Investigators (ESIs).
Jian Hu receives Sontag Foundation Distinguished Scientist Award
Jian Hu, Ph.D., received the Sontag Foundation Distinguished Scientist Award, which provides career and research support to early career scientists who demonstrate outstanding promise for making scientific and medical breakthroughs in the field of brain cancer research.
Yejing Ge receives AACR NextGen Star award
Yejing Ge, Ph.D., receives the 2018 AACR’s NextGen Star award, an accolade to recognize uprising early-career scientists and support their professional advancement.
The Cancer Biology department invites distinguished speakers for giving lectures, followed by a “chalk talk”, featuring the speakers’ stories in their career and scientific pursuit. Keep tuned with new sessions of sciChat!